Contract facts
FederalADD CLIN 0011 ARM ENHANCEMENTS AND EXTEND THRU 31 MAR 2022 is a federal award for Ustranscom-Aq held by Raytheon Bbn Technologies Corp. Estimated value $9.6M ($379K obligated). Current period of performance ends Sep 30, 2022. Place of performance: CAMBRIDGE MA. Related solicitation HTC71117RD001.
ADD CLIN 0011 ARM ENHANCEMENTS AND EXTEND THRU 31 MAR 2022
Recompete timing
PublicCurrent PoP ended Sep 30, 2022 (1421 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordRaytheon Bbn Technologies Corp — $257.9M obligated across 331 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HTC71121FD019?
HTC71121FD019 (ADD CLIN 0011 ARM enhancements and) is a Ustranscom-Aq award with a potential value of $9.6M, currently held by Raytheon Bbn Technologies Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded HTC71121FD019?
Ustranscom-Aq awarded HTC71121FD019 to Raytheon Bbn Technologies Corp (potential $9.6M).
Who is the incumbent on HTC71121FD019?
Raytheon Bbn Technologies Corp is the incumbent with $257.9M across 331 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2022.
When does Raytheon Bbn Technologies Corp’s HTC71121FD019 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
